Legacy CG’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-9,310
Closed -$4.74M 62
2024
Q2
$4.74M Sell
9,310
-274
-3% -$134K 1.61% 30
2024
Q1
$4.74M Buy
9,584
+217
+2% +$110K 1.72% 28
2023
Q4
$4.93M Buy
9,367
+452
+5% +$241K 1.87% 22
2023
Q3
$4.49M Buy
8,915
+614
+7% +$302K 2.09% 12
2023
Q2
$3.99M Buy
8,301
+527
+7% +$258K 1.84% 20
2023
Q1
$3.67M Buy
7,774
+577
+8% +$278K 1.86% 16
2022
Q4
$3.82M Buy
7,197
+53
+0.7% +$28.1K 2.24% 15
2022
Q3
$3.61M Buy
7,144
+79
+1% +$41.5K 2.38% 13
2022
Q2
$3.63M Buy
7,065
+74
+1% +$37.2K 2.5% 9
2022
Q1
$3.56M Buy
+6,991
New +$3.37M 2.32% 15

Other funds holding UNH

Legacy CG's UNH Position: Q3 2024 in Review

Legacy CG sold out of UnitedHealth (UNH) in Q3 2024, closing a stake of 9,310 shares — an estimated $4.74M sold.

Legacy CG first reported a position in UNH in Q1 2022 and held it in 10 quarters. The position peaked at $4.93M in Q4 2023. 3,465 funds tracked by Wall St. Rank hold UNH as of Q3 2024.

  • Legacy CG reported no remaining UnitedHealth position as of Q3 2024 after selling out during the quarter.
  • Legacy CG sold 9,310 UnitedHealth shares in Q3 2024, an estimated $4.74M.
  • Legacy CG first reported a position in UnitedHealth in Q1 2022 and held it in 10 quarters.
  • Legacy CG's UnitedHealth position peaked at $4.93M in Q4 2023.
  • 3,465 funds tracked by Wall St. Rank held UnitedHealth as of Q3 2024.

Based on Legacy CG's 13F filing for Q3 2024, filed 30 Oct 2024.